Company Nanobac Pharmaceuticals, Incorporated
Equities
NNBP
US63007M1027
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic & Diagn
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -92.17% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Finland
96.9
%
| 0 | 9.2 % | 0 | 96.9 % | -17.94% |
United States
3.1
%
| 0 | 90.8 % | 0 | 3.1 % | -99.74% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 249,506,760 | 249,506,760 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Nanobac Pharmaceuticals, Inc.
5025 West Lemon Street
33609, Tampa
+
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
0.00% | 249 | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- NNBP Stock
- Company Nanobac Pharmaceuticals, Incorporated